Multiple Sclerosis (MS) is an autoimmune inflammatory disease that affects the Central Nervous System (CNS) by interfering with nerve signal transmission. Approximately 10-15% of individuals diagnosed with Multiple Sclerosis are diagnosed with Primary Progressive Multiple Sclerosis (PPMS). Symptoms of PPMS are similar to that of MS, yet there are no relapses or remissions and symptoms consistently worsen overtime. PPMS directly affects the spinal cord, so issues with walking, balance, and movement are frequently observed. In PPMS, there is little inflammation and the symptoms are caused by damage to the nerves which commonly create plaques or lesions at the nerve endings.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Primary Progressive Multiple Sclerosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 1957 products for the study of Primary Progressive Multiple Sclerosis that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.